Maghanoy, Krystal Jane .
HRN: 26-00-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/08/2024
10/15/2024
IVT
500 Mg
Q8h
Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes